The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 1,119 | 23,895 |
| Depreciation and amortization | 21,431 | 40,641 |
| Loss on extinguishment of debt | 0 | - |
| Amortization of debt issuance costs and discounts | 445 | 869 |
| Non-cash operating lease expense | 998 | 2,065 |
| Stock-based compensation expense | 18,118 | 40,589 |
| Deferred income taxes | 8,089 | - |
| Loss on operating lease asset | 0 | 4,409 |
| Other | 20 | 456 |
| Accounts receivable | 14,711 | 43,093 |
| Prepaid expenses and other assets | 7,437 | 15,796 |
| Accounts payable | 3,539 | 11,086 |
| Accrued expenses and other current liabilities | 45,443 | -3,235 |
| Operating lease liabilities | -1,545 | -3,187 |
| Other liabilities | 514 | 294 |
| Net cash provided by operating activities | 76,023 | 58,993 |
| Purchase of property and equipment | 1,748 | 532 |
| Acquisition | 0 | 30,000 |
| Capitalized software | 16,251 | 39,659 |
| Net cash used in investing activities | -17,999 | -70,191 |
| Proceeds from long-term debt | 0 | - |
| Payments on long-term debt | 1,250 | 2,500 |
| Payments of debt issuance costs | 0 | - |
| Repurchases of class a common stock | 61,054 | 145,888 |
| Proceeds from exercise of stock options | 58 | 3 |
| Employee taxes paid related to net share settlement of equity awards | 3,567 | 8,305 |
| Proceeds from employee stock purchase plan | 0 | 860 |
| Net cash used in financing activities | -65,813 | -155,830 |
| Net change in cash and cash equivalents | -7,789 | -167,028 |
| Cash and cash equivalents at beginning of period | 448,346 | - |
| Cash and cash equivalents at end of period | 273,529 | - |
GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. (GDRX)